nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2C9—Fenofibrate—coronary artery disease	0.0499	0.0769	CbGbCtD
Alosetron—CYP1A2—Gemfibrozil—coronary artery disease	0.0443	0.0683	CbGbCtD
Alosetron—CYP2C9—Gemfibrozil—coronary artery disease	0.0399	0.0615	CbGbCtD
Alosetron—CYP1A2—Clopidogrel—coronary artery disease	0.0384	0.0592	CbGbCtD
Alosetron—CYP2C9—Clopidogrel—coronary artery disease	0.0346	0.0533	CbGbCtD
Alosetron—CYP3A4—Ticagrelor—coronary artery disease	0.0326	0.0502	CbGbCtD
Alosetron—CYP2C9—Pitavastatin—coronary artery disease	0.0302	0.0466	CbGbCtD
Alosetron—CYP2C9—Valsartan—coronary artery disease	0.0294	0.0453	CbGbCtD
Alosetron—CYP3A4—Fenofibrate—coronary artery disease	0.029	0.0447	CbGbCtD
Alosetron—CYP3A4—Gemfibrozil—coronary artery disease	0.0232	0.0358	CbGbCtD
Alosetron—CYP2C9—Rosuvastatin—coronary artery disease	0.0223	0.0344	CbGbCtD
Alosetron—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0217	0.0335	CbGbCtD
Alosetron—CYP2C9—Simvastatin—coronary artery disease	0.0207	0.032	CbGbCtD
Alosetron—CYP2C9—Lovastatin—coronary artery disease	0.0203	0.0313	CbGbCtD
Alosetron—CYP2C9—Pravastatin—coronary artery disease	0.0203	0.0313	CbGbCtD
Alosetron—CYP3A4—Clopidogrel—coronary artery disease	0.0201	0.031	CbGbCtD
Alosetron—CYP1A2—Losartan—coronary artery disease	0.0187	0.0289	CbGbCtD
Alosetron—CYP3A4—Eplerenone—coronary artery disease	0.0187	0.0288	CbGbCtD
Alosetron—CYP2C9—Atorvastatin—coronary artery disease	0.0185	0.0285	CbGbCtD
Alosetron—CYP2C9—Losartan—coronary artery disease	0.0169	0.026	CbGbCtD
Alosetron—CYP3A4—Enalapril—coronary artery disease	0.0167	0.0257	CbGbCtD
Alosetron—CYP3A4—Rosuvastatin—coronary artery disease	0.013	0.02	CbGbCtD
Alosetron—CYP3A4—Ezetimibe—coronary artery disease	0.013	0.02	CbGbCtD
Alosetron—CYP3A4—Simvastatin—coronary artery disease	0.012	0.0186	CbGbCtD
Alosetron—CYP3A4—Lovastatin—coronary artery disease	0.0118	0.0182	CbGbCtD
Alosetron—CYP3A4—Pravastatin—coronary artery disease	0.0118	0.0182	CbGbCtD
Alosetron—CYP3A4—Atorvastatin—coronary artery disease	0.0107	0.0166	CbGbCtD
Alosetron—CYP3A4—Losartan—coronary artery disease	0.00982	0.0151	CbGbCtD
Alosetron—CYP2C9—cardial valve—coronary artery disease	0.00877	0.46	CbGeAlD
Alosetron—HTR3A—vagus nerve—coronary artery disease	0.00683	0.358	CbGeAlD
Alosetron—HTR3A—blood—coronary artery disease	0.000739	0.0387	CbGeAlD
Alosetron—CYP2C9—heart—coronary artery disease	0.000485	0.0254	CbGeAlD
Alosetron—CYP2C9—cardiovascular system—coronary artery disease	0.000457	0.024	CbGeAlD
Alosetron—CYP2E1—cardiovascular system—coronary artery disease	0.000434	0.0227	CbGeAlD
Alosetron—CYP1A2—blood—coronary artery disease	0.000381	0.02	CbGeAlD
Alosetron—CYP2C9—blood—coronary artery disease	0.000362	0.019	CbGeAlD
Alosetron—CYP2E1—blood—coronary artery disease	0.000343	0.018	CbGeAlD
Alosetron—CYP3A4—blood—coronary artery disease	0.000276	0.0145	CbGeAlD
Alosetron—Anxiety—Losartan—coronary artery disease	0.00015	0.000559	CcSEcCtD
Alosetron—Hypersensitivity—Clopidogrel—coronary artery disease	0.00015	0.000558	CcSEcCtD
Alosetron—Skin disorder—Perindopril—coronary artery disease	0.00015	0.000557	CcSEcCtD
Alosetron—Headache—Rosuvastatin—coronary artery disease	0.000149	0.000557	CcSEcCtD
Alosetron—Hypersensitivity—Lovastatin—coronary artery disease	0.000149	0.000555	CcSEcCtD
Alosetron—Hyperhidrosis—Perindopril—coronary artery disease	0.000149	0.000554	CcSEcCtD
Alosetron—Discomfort—Losartan—coronary artery disease	0.000149	0.000554	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Telmisartan—coronary artery disease	0.000149	0.000553	CcSEcCtD
Alosetron—Asthenia—Fenofibrate—coronary artery disease	0.000149	0.000553	CcSEcCtD
Alosetron—Pain—Niacin—coronary artery disease	0.000148	0.000553	CcSEcCtD
Alosetron—Fatigue—Pravastatin—coronary artery disease	0.000147	0.000549	CcSEcCtD
Alosetron—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000147	0.000549	CcSEcCtD
Alosetron—Dry mouth—Losartan—coronary artery disease	0.000147	0.000549	CcSEcCtD
Alosetron—Feeling abnormal—Olmesartan—coronary artery disease	0.000146	0.000545	CcSEcCtD
Alosetron—Pain—Pravastatin—coronary artery disease	0.000146	0.000544	CcSEcCtD
Alosetron—Constipation—Pravastatin—coronary artery disease	0.000146	0.000544	CcSEcCtD
Alosetron—Rash—Acetylsalicylic acid—coronary artery disease	0.000146	0.000544	CcSEcCtD
Alosetron—Hypersensitivity—Ezetimibe—coronary artery disease	0.000146	0.000544	CcSEcCtD
Alosetron—Asthenia—Clopidogrel—coronary artery disease	0.000146	0.000544	CcSEcCtD
Alosetron—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000146	0.000544	CcSEcCtD
Alosetron—Muscle spasms—Ramipril—coronary artery disease	0.000146	0.000543	CcSEcCtD
Alosetron—Confusional state—Losartan—coronary artery disease	0.000146	0.000542	CcSEcCtD
Alosetron—Skin disorder—Furosemide—coronary artery disease	0.000145	0.000541	CcSEcCtD
Alosetron—Asthenia—Lovastatin—coronary artery disease	0.000145	0.00054	CcSEcCtD
Alosetron—Hyperhidrosis—Furosemide—coronary artery disease	0.000145	0.000539	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Captopril—coronary artery disease	0.000144	0.000538	CcSEcCtD
Alosetron—Infection—Losartan—coronary artery disease	0.000143	0.000534	CcSEcCtD
Alosetron—Fatigue—Trandolapril—coronary artery disease	0.000143	0.000533	CcSEcCtD
Alosetron—Fatigue—Enalapril—coronary artery disease	0.000143	0.000531	CcSEcCtD
Alosetron—Asthenia—Ezetimibe—coronary artery disease	0.000142	0.00053	CcSEcCtD
Alosetron—Tremor—Ramipril—coronary artery disease	0.000142	0.000529	CcSEcCtD
Alosetron—Constipation—Trandolapril—coronary artery disease	0.000142	0.000529	CcSEcCtD
Alosetron—Urticaria—Valsartan—coronary artery disease	0.000142	0.000528	CcSEcCtD
Alosetron—Nausea—Rosuvastatin—coronary artery disease	0.000142	0.000528	CcSEcCtD
Alosetron—Constipation—Enalapril—coronary artery disease	0.000141	0.000527	CcSEcCtD
Alosetron—Arrhythmia—Lisinopril—coronary artery disease	0.000141	0.000526	CcSEcCtD
Alosetron—Urticaria—Olmesartan—coronary artery disease	0.000141	0.000526	CcSEcCtD
Alosetron—Feeling abnormal—Pravastatin—coronary artery disease	0.000141	0.000525	CcSEcCtD
Alosetron—Ill-defined disorder—Ramipril—coronary artery disease	0.000141	0.000524	CcSEcCtD
Alosetron—Fatigue—Telmisartan—coronary artery disease	0.000141	0.000524	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.00014	0.000522	CcSEcCtD
Alosetron—Alopecia—Lisinopril—coronary artery disease	0.00014	0.00052	CcSEcCtD
Alosetron—Hyperhidrosis—Losartan—coronary artery disease	0.00014	0.00052	CcSEcCtD
Alosetron—Pain—Telmisartan—coronary artery disease	0.000139	0.000519	CcSEcCtD
Alosetron—Constipation—Telmisartan—coronary artery disease	0.000139	0.000519	CcSEcCtD
Alosetron—Hypersensitivity—Simvastatin—coronary artery disease	0.000139	0.000519	CcSEcCtD
Alosetron—Asthenia—Eplerenone—coronary artery disease	0.000139	0.000519	CcSEcCtD
Alosetron—Urticaria—Niacin—coronary artery disease	0.000138	0.000514	CcSEcCtD
Alosetron—Nausea—Acetylsalicylic acid—coronary artery disease	0.000138	0.000513	CcSEcCtD
Alosetron—Malaise—Ramipril—coronary artery disease	0.000137	0.00051	CcSEcCtD
Alosetron—Feeling abnormal—Trandolapril—coronary artery disease	0.000137	0.000509	CcSEcCtD
Alosetron—Fatigue—Captopril—coronary artery disease	0.000137	0.000509	CcSEcCtD
Alosetron—Feeling abnormal—Enalapril—coronary artery disease	0.000136	0.000507	CcSEcCtD
Alosetron—Urticaria—Pravastatin—coronary artery disease	0.000136	0.000506	CcSEcCtD
Alosetron—Asthenia—Simvastatin—coronary artery disease	0.000136	0.000505	CcSEcCtD
Alosetron—Constipation—Captopril—coronary artery disease	0.000136	0.000505	CcSEcCtD
Alosetron—Flatulence—Lisinopril—coronary artery disease	0.000136	0.000505	CcSEcCtD
Alosetron—Feeling abnormal—Telmisartan—coronary artery disease	0.000134	0.0005	CcSEcCtD
Alosetron—Fatigue—Perindopril—coronary artery disease	0.000133	0.000494	CcSEcCtD
Alosetron—Cough—Ramipril—coronary artery disease	0.000132	0.000493	CcSEcCtD
Alosetron—Muscle spasms—Lisinopril—coronary artery disease	0.000132	0.000493	CcSEcCtD
Alosetron—Urticaria—Trandolapril—coronary artery disease	0.000132	0.000491	CcSEcCtD
Alosetron—Constipation—Perindopril—coronary artery disease	0.000132	0.00049	CcSEcCtD
Alosetron—Pain—Perindopril—coronary artery disease	0.000132	0.00049	CcSEcCtD
Alosetron—Vomiting—Fenofibrate—coronary artery disease	0.000132	0.00049	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000132	0.00049	CcSEcCtD
Alosetron—Hypersensitivity—Valsartan—coronary artery disease	0.000132	0.00049	CcSEcCtD
Alosetron—Urticaria—Enalapril—coronary artery disease	0.000131	0.000489	CcSEcCtD
Alosetron—Feeling abnormal—Captopril—coronary artery disease	0.000131	0.000487	CcSEcCtD
Alosetron—Rash—Fenofibrate—coronary artery disease	0.000131	0.000486	CcSEcCtD
Alosetron—Dermatitis—Fenofibrate—coronary artery disease	0.00013	0.000486	CcSEcCtD
Alosetron—Headache—Fenofibrate—coronary artery disease	0.00013	0.000483	CcSEcCtD
Alosetron—Urticaria—Telmisartan—coronary artery disease	0.00013	0.000482	CcSEcCtD
Alosetron—Cough—Timolol—coronary artery disease	0.000129	0.000482	CcSEcCtD
Alosetron—Vomiting—Clopidogrel—coronary artery disease	0.000129	0.000482	CcSEcCtD
Alosetron—Myalgia—Ramipril—coronary artery disease	0.000129	0.000481	CcSEcCtD
Alosetron—Fatigue—Furosemide—coronary artery disease	0.000129	0.000481	CcSEcCtD
Alosetron—Tremor—Lisinopril—coronary artery disease	0.000129	0.00048	CcSEcCtD
Alosetron—Anxiety—Ramipril—coronary artery disease	0.000129	0.000479	CcSEcCtD
Alosetron—Vomiting—Lovastatin—coronary artery disease	0.000129	0.000479	CcSEcCtD
Alosetron—Rash—Clopidogrel—coronary artery disease	0.000128	0.000478	CcSEcCtD
Alosetron—Dermatitis—Clopidogrel—coronary artery disease	0.000128	0.000477	CcSEcCtD
Alosetron—Asthenia—Valsartan—coronary artery disease	0.000128	0.000477	CcSEcCtD
Alosetron—Hypertension—Timolol—coronary artery disease	0.000128	0.000477	CcSEcCtD
Alosetron—Constipation—Furosemide—coronary artery disease	0.000128	0.000477	CcSEcCtD
Alosetron—Pain—Furosemide—coronary artery disease	0.000128	0.000477	CcSEcCtD
Alosetron—Hypersensitivity—Niacin—coronary artery disease	0.000128	0.000476	CcSEcCtD
Alosetron—Ill-defined disorder—Lisinopril—coronary artery disease	0.000128	0.000475	CcSEcCtD
Alosetron—Discomfort—Ramipril—coronary artery disease	0.000128	0.000475	CcSEcCtD
Alosetron—Asthenia—Olmesartan—coronary artery disease	0.000128	0.000475	CcSEcCtD
Alosetron—Headache—Clopidogrel—coronary artery disease	0.000127	0.000475	CcSEcCtD
Alosetron—Rash—Lovastatin—coronary artery disease	0.000127	0.000475	CcSEcCtD
Alosetron—Dermatitis—Lovastatin—coronary artery disease	0.000127	0.000474	CcSEcCtD
Alosetron—Feeling abnormal—Perindopril—coronary artery disease	0.000127	0.000473	CcSEcCtD
Alosetron—Headache—Lovastatin—coronary artery disease	0.000127	0.000472	CcSEcCtD
Alosetron—Dry mouth—Ramipril—coronary artery disease	0.000126	0.00047	CcSEcCtD
Alosetron—Myalgia—Timolol—coronary artery disease	0.000126	0.00047	CcSEcCtD
Alosetron—Vomiting—Ezetimibe—coronary artery disease	0.000126	0.000469	CcSEcCtD
Alosetron—Hypersensitivity—Pravastatin—coronary artery disease	0.000126	0.000469	CcSEcCtD
Alosetron—Anxiety—Timolol—coronary artery disease	0.000126	0.000469	CcSEcCtD
Alosetron—Rash—Ezetimibe—coronary artery disease	0.000125	0.000466	CcSEcCtD
Alosetron—Dermatitis—Ezetimibe—coronary artery disease	0.000125	0.000465	CcSEcCtD
Alosetron—Confusional state—Ramipril—coronary artery disease	0.000125	0.000465	CcSEcCtD
Alosetron—Discomfort—Timolol—coronary artery disease	0.000125	0.000465	CcSEcCtD
Alosetron—Asthenia—Niacin—coronary artery disease	0.000125	0.000464	CcSEcCtD
Alosetron—Fatigue—Losartan—coronary artery disease	0.000125	0.000464	CcSEcCtD
Alosetron—Headache—Ezetimibe—coronary artery disease	0.000124	0.000463	CcSEcCtD
Alosetron—Malaise—Lisinopril—coronary artery disease	0.000124	0.000462	CcSEcCtD
Alosetron—Dry mouth—Timolol—coronary artery disease	0.000124	0.00046	CcSEcCtD
Alosetron—Constipation—Losartan—coronary artery disease	0.000124	0.00046	CcSEcCtD
Alosetron—Pain—Losartan—coronary artery disease	0.000124	0.00046	CcSEcCtD
Alosetron—Vomiting—Eplerenone—coronary artery disease	0.000123	0.00046	CcSEcCtD
Alosetron—Feeling abnormal—Furosemide—coronary artery disease	0.000123	0.000459	CcSEcCtD
Alosetron—Nausea—Fenofibrate—coronary artery disease	0.000123	0.000458	CcSEcCtD
Alosetron—Asthenia—Pravastatin—coronary artery disease	0.000123	0.000457	CcSEcCtD
Alosetron—Rash—Eplerenone—coronary artery disease	0.000122	0.000456	CcSEcCtD
Alosetron—Urticaria—Perindopril—coronary artery disease	0.000122	0.000456	CcSEcCtD
Alosetron—Hypersensitivity—Trandolapril—coronary artery disease	0.000122	0.000455	CcSEcCtD
Alosetron—Dermatitis—Eplerenone—coronary artery disease	0.000122	0.000455	CcSEcCtD
Alosetron—Confusional state—Timolol—coronary artery disease	0.000122	0.000455	CcSEcCtD
Alosetron—Hypersensitivity—Enalapril—coronary artery disease	0.000122	0.000454	CcSEcCtD
Alosetron—Headache—Eplerenone—coronary artery disease	0.000122	0.000453	CcSEcCtD
Alosetron—Nausea—Clopidogrel—coronary artery disease	0.000121	0.00045	CcSEcCtD
Alosetron—Skin disorder—Ramipril—coronary artery disease	0.00012	0.000448	CcSEcCtD
Alosetron—Infection—Timolol—coronary artery disease	0.00012	0.000448	CcSEcCtD
Alosetron—Vomiting—Simvastatin—coronary artery disease	0.00012	0.000448	CcSEcCtD
Alosetron—Hypersensitivity—Telmisartan—coronary artery disease	0.00012	0.000447	CcSEcCtD
Alosetron—Cough—Lisinopril—coronary artery disease	0.00012	0.000447	CcSEcCtD
Alosetron—Nausea—Lovastatin—coronary artery disease	0.00012	0.000447	CcSEcCtD
Alosetron—Hyperhidrosis—Ramipril—coronary artery disease	0.00012	0.000446	CcSEcCtD
Alosetron—Rash—Simvastatin—coronary artery disease	0.000119	0.000444	CcSEcCtD
Alosetron—Dermatitis—Simvastatin—coronary artery disease	0.000119	0.000444	CcSEcCtD
Alosetron—Asthenia—Trandolapril—coronary artery disease	0.000119	0.000444	CcSEcCtD
Alosetron—Feeling abnormal—Losartan—coronary artery disease	0.000119	0.000443	CcSEcCtD
Alosetron—Urticaria—Furosemide—coronary artery disease	0.000119	0.000443	CcSEcCtD
Alosetron—Asthenia—Enalapril—coronary artery disease	0.000119	0.000442	CcSEcCtD
Alosetron—Headache—Simvastatin—coronary artery disease	0.000118	0.000441	CcSEcCtD
Alosetron—Nausea—Ezetimibe—coronary artery disease	0.000118	0.000439	CcSEcCtD
Alosetron—Skin disorder—Timolol—coronary artery disease	0.000118	0.000438	CcSEcCtD
Alosetron—Myalgia—Lisinopril—coronary artery disease	0.000117	0.000436	CcSEcCtD
Alosetron—Hyperhidrosis—Timolol—coronary artery disease	0.000117	0.000436	CcSEcCtD
Alosetron—Asthenia—Telmisartan—coronary artery disease	0.000117	0.000436	CcSEcCtD
Alosetron—Anxiety—Lisinopril—coronary artery disease	0.000117	0.000435	CcSEcCtD
Alosetron—Discomfort—Lisinopril—coronary artery disease	0.000116	0.000431	CcSEcCtD
Alosetron—Nausea—Eplerenone—coronary artery disease	0.000115	0.000429	CcSEcCtD
Alosetron—Urticaria—Losartan—coronary artery disease	0.000115	0.000427	CcSEcCtD
Alosetron—Dry mouth—Lisinopril—coronary artery disease	0.000115	0.000427	CcSEcCtD
Alosetron—Asthenia—Captopril—coronary artery disease	0.000114	0.000424	CcSEcCtD
Alosetron—Vomiting—Valsartan—coronary artery disease	0.000114	0.000423	CcSEcCtD
Alosetron—Confusional state—Lisinopril—coronary artery disease	0.000113	0.000422	CcSEcCtD
Alosetron—Vomiting—Olmesartan—coronary artery disease	0.000113	0.000421	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000113	0.00042	CcSEcCtD
Alosetron—Rash—Valsartan—coronary artery disease	0.000113	0.000419	CcSEcCtD
Alosetron—Dermatitis—Valsartan—coronary artery disease	0.000112	0.000419	CcSEcCtD
Alosetron—Nausea—Simvastatin—coronary artery disease	0.000112	0.000418	CcSEcCtD
Alosetron—Rash—Olmesartan—coronary artery disease	0.000112	0.000417	CcSEcCtD
Alosetron—Dermatitis—Olmesartan—coronary artery disease	0.000112	0.000417	CcSEcCtD
Alosetron—Headache—Valsartan—coronary artery disease	0.000112	0.000417	CcSEcCtD
Alosetron—Infection—Lisinopril—coronary artery disease	0.000112	0.000416	CcSEcCtD
Alosetron—Headache—Olmesartan—coronary artery disease	0.000111	0.000415	CcSEcCtD
Alosetron—Asthenia—Perindopril—coronary artery disease	0.00011	0.000411	CcSEcCtD
Alosetron—Vomiting—Niacin—coronary artery disease	0.00011	0.000411	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Timolol—coronary artery disease	0.00011	0.000411	CcSEcCtD
Alosetron—Hypersensitivity—Furosemide—coronary artery disease	0.00011	0.000411	CcSEcCtD
Alosetron—Rash—Niacin—coronary artery disease	0.000109	0.000408	CcSEcCtD
Alosetron—Dermatitis—Niacin—coronary artery disease	0.000109	0.000407	CcSEcCtD
Alosetron—Skin disorder—Lisinopril—coronary artery disease	0.000109	0.000406	CcSEcCtD
Alosetron—Headache—Niacin—coronary artery disease	0.000109	0.000405	CcSEcCtD
Alosetron—Vomiting—Pravastatin—coronary artery disease	0.000109	0.000405	CcSEcCtD
Alosetron—Hyperhidrosis—Lisinopril—coronary artery disease	0.000109	0.000404	CcSEcCtD
Alosetron—Rash—Pravastatin—coronary artery disease	0.000108	0.000401	CcSEcCtD
Alosetron—Dermatitis—Pravastatin—coronary artery disease	0.000108	0.000401	CcSEcCtD
Alosetron—Asthenia—Furosemide—coronary artery disease	0.000107	0.0004	CcSEcCtD
Alosetron—Headache—Pravastatin—coronary artery disease	0.000107	0.000399	CcSEcCtD
Alosetron—Fatigue—Ramipril—coronary artery disease	0.000107	0.000398	CcSEcCtD
Alosetron—Hypersensitivity—Losartan—coronary artery disease	0.000106	0.000396	CcSEcCtD
Alosetron—Nausea—Valsartan—coronary artery disease	0.000106	0.000395	CcSEcCtD
Alosetron—Constipation—Ramipril—coronary artery disease	0.000106	0.000394	CcSEcCtD
Alosetron—Nausea—Olmesartan—coronary artery disease	0.000106	0.000393	CcSEcCtD
Alosetron—Vomiting—Trandolapril—coronary artery disease	0.000106	0.000393	CcSEcCtD
Alosetron—Vomiting—Enalapril—coronary artery disease	0.000105	0.000392	CcSEcCtD
Alosetron—Rash—Trandolapril—coronary artery disease	0.000105	0.00039	CcSEcCtD
Alosetron—Dermatitis—Trandolapril—coronary artery disease	0.000105	0.000389	CcSEcCtD
Alosetron—Fatigue—Timolol—coronary artery disease	0.000104	0.000389	CcSEcCtD
Alosetron—Rash—Enalapril—coronary artery disease	0.000104	0.000388	CcSEcCtD
Alosetron—Dermatitis—Enalapril—coronary artery disease	0.000104	0.000388	CcSEcCtD
Alosetron—Headache—Trandolapril—coronary artery disease	0.000104	0.000387	CcSEcCtD
Alosetron—Vomiting—Telmisartan—coronary artery disease	0.000104	0.000386	CcSEcCtD
Alosetron—Asthenia—Losartan—coronary artery disease	0.000104	0.000386	CcSEcCtD
Alosetron—Headache—Enalapril—coronary artery disease	0.000104	0.000386	CcSEcCtD
Alosetron—Pain—Timolol—coronary artery disease	0.000104	0.000386	CcSEcCtD
Alosetron—Nausea—Niacin—coronary artery disease	0.000103	0.000384	CcSEcCtD
Alosetron—Rash—Telmisartan—coronary artery disease	0.000103	0.000383	CcSEcCtD
Alosetron—Dermatitis—Telmisartan—coronary artery disease	0.000103	0.000383	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000102	0.000381	CcSEcCtD
Alosetron—Headache—Telmisartan—coronary artery disease	0.000102	0.00038	CcSEcCtD
Alosetron—Feeling abnormal—Ramipril—coronary artery disease	0.000102	0.00038	CcSEcCtD
Alosetron—Nausea—Pravastatin—coronary artery disease	0.000102	0.000378	CcSEcCtD
Alosetron—Vomiting—Captopril—coronary artery disease	0.000101	0.000375	CcSEcCtD
Alosetron—Rash—Captopril—coronary artery disease	0.0001	0.000372	CcSEcCtD
Alosetron—Dermatitis—Captopril—coronary artery disease	9.99e-05	0.000372	CcSEcCtD
Alosetron—Feeling abnormal—Timolol—coronary artery disease	9.98e-05	0.000372	CcSEcCtD
Alosetron—Headache—Captopril—coronary artery disease	9.93e-05	0.00037	CcSEcCtD
Alosetron—Nausea—Trandolapril—coronary artery disease	9.86e-05	0.000367	CcSEcCtD
Alosetron—Urticaria—Ramipril—coronary artery disease	9.84e-05	0.000366	CcSEcCtD
Alosetron—Nausea—Enalapril—coronary artery disease	9.82e-05	0.000366	CcSEcCtD
Alosetron—Vomiting—Perindopril—coronary artery disease	9.79e-05	0.000365	CcSEcCtD
Alosetron—Rash—Perindopril—coronary artery disease	9.71e-05	0.000362	CcSEcCtD
Alosetron—Dermatitis—Perindopril—coronary artery disease	9.7e-05	0.000361	CcSEcCtD
Alosetron—Nausea—Telmisartan—coronary artery disease	9.69e-05	0.000361	CcSEcCtD
Alosetron—Fatigue—Lisinopril—coronary artery disease	9.68e-05	0.000361	CcSEcCtD
Alosetron—Headache—Perindopril—coronary artery disease	9.65e-05	0.000359	CcSEcCtD
Alosetron—Urticaria—Timolol—coronary artery disease	9.62e-05	0.000358	CcSEcCtD
Alosetron—Constipation—Lisinopril—coronary artery disease	9.6e-05	0.000358	CcSEcCtD
Alosetron—Pain—Lisinopril—coronary artery disease	9.6e-05	0.000358	CcSEcCtD
Alosetron—Vomiting—Furosemide—coronary artery disease	9.52e-05	0.000354	CcSEcCtD
Alosetron—Rash—Furosemide—coronary artery disease	9.44e-05	0.000351	CcSEcCtD
Alosetron—Dermatitis—Furosemide—coronary artery disease	9.43e-05	0.000351	CcSEcCtD
Alosetron—Nausea—Captopril—coronary artery disease	9.42e-05	0.000351	CcSEcCtD
Alosetron—Headache—Furosemide—coronary artery disease	9.38e-05	0.000349	CcSEcCtD
Alosetron—Feeling abnormal—Lisinopril—coronary artery disease	9.25e-05	0.000345	CcSEcCtD
Alosetron—Vomiting—Losartan—coronary artery disease	9.18e-05	0.000342	CcSEcCtD
Alosetron—Nausea—Perindopril—coronary artery disease	9.15e-05	0.000341	CcSEcCtD
Alosetron—Hypersensitivity—Ramipril—coronary artery disease	9.12e-05	0.00034	CcSEcCtD
Alosetron—Rash—Losartan—coronary artery disease	9.11e-05	0.000339	CcSEcCtD
Alosetron—Dermatitis—Losartan—coronary artery disease	9.1e-05	0.000339	CcSEcCtD
Alosetron—Headache—Losartan—coronary artery disease	9.05e-05	0.000337	CcSEcCtD
Alosetron—Urticaria—Lisinopril—coronary artery disease	8.92e-05	0.000332	CcSEcCtD
Alosetron—Hypersensitivity—Timolol—coronary artery disease	8.92e-05	0.000332	CcSEcCtD
Alosetron—Nausea—Furosemide—coronary artery disease	8.89e-05	0.000331	CcSEcCtD
Alosetron—Asthenia—Ramipril—coronary artery disease	8.88e-05	0.000331	CcSEcCtD
Alosetron—Asthenia—Timolol—coronary artery disease	8.69e-05	0.000323	CcSEcCtD
Alosetron—Nausea—Losartan—coronary artery disease	8.58e-05	0.000319	CcSEcCtD
Alosetron—Hypersensitivity—Lisinopril—coronary artery disease	8.27e-05	0.000308	CcSEcCtD
Alosetron—Asthenia—Lisinopril—coronary artery disease	8.06e-05	0.0003	CcSEcCtD
Alosetron—Vomiting—Ramipril—coronary artery disease	7.87e-05	0.000293	CcSEcCtD
Alosetron—Rash—Ramipril—coronary artery disease	7.81e-05	0.000291	CcSEcCtD
Alosetron—Dermatitis—Ramipril—coronary artery disease	7.8e-05	0.000291	CcSEcCtD
Alosetron—Headache—Ramipril—coronary artery disease	7.76e-05	0.000289	CcSEcCtD
Alosetron—Vomiting—Timolol—coronary artery disease	7.7e-05	0.000287	CcSEcCtD
Alosetron—Rash—Timolol—coronary artery disease	7.63e-05	0.000284	CcSEcCtD
Alosetron—Dermatitis—Timolol—coronary artery disease	7.63e-05	0.000284	CcSEcCtD
Alosetron—Headache—Timolol—coronary artery disease	7.58e-05	0.000282	CcSEcCtD
Alosetron—Nausea—Ramipril—coronary artery disease	7.36e-05	0.000274	CcSEcCtD
Alosetron—Nausea—Timolol—coronary artery disease	7.19e-05	0.000268	CcSEcCtD
Alosetron—Vomiting—Lisinopril—coronary artery disease	7.14e-05	0.000266	CcSEcCtD
Alosetron—Rash—Lisinopril—coronary artery disease	7.08e-05	0.000264	CcSEcCtD
Alosetron—Dermatitis—Lisinopril—coronary artery disease	7.07e-05	0.000263	CcSEcCtD
Alosetron—Headache—Lisinopril—coronary artery disease	7.04e-05	0.000262	CcSEcCtD
Alosetron—Nausea—Lisinopril—coronary artery disease	6.67e-05	0.000248	CcSEcCtD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.24e-05	0.000194	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CKB—coronary artery disease	1.23e-05	0.000192	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PYGB—coronary artery disease	1.23e-05	0.000192	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HADHA—coronary artery disease	1.23e-05	0.000192	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.23e-05	0.000192	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PSMA6—coronary artery disease	1.22e-05	0.000191	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PSMB5—coronary artery disease	1.22e-05	0.000191	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTA1—coronary artery disease	1.21e-05	0.00019	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PDHA1—coronary artery disease	1.21e-05	0.000189	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GCLM—coronary artery disease	1.21e-05	0.000189	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—LPA—coronary artery disease	1.2e-05	0.000188	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CTGF—coronary artery disease	1.19e-05	0.000187	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HMGCR—coronary artery disease	1.18e-05	0.000185	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GOT2—coronary artery disease	1.18e-05	0.000185	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.17e-05	0.000183	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—TXNRD1—coronary artery disease	1.17e-05	0.000183	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP11B2—coronary artery disease	1.17e-05	0.000183	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PLCB3—coronary artery disease	1.16e-05	0.000182	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—COX5B—coronary artery disease	1.16e-05	0.000181	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—DLAT—coronary artery disease	1.16e-05	0.000181	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.16e-05	0.000181	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.16e-05	0.000181	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.16e-05	0.000181	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC22A3—coronary artery disease	1.15e-05	0.00018	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—APOA5—coronary artery disease	1.15e-05	0.00018	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HADH—coronary artery disease	1.14e-05	0.000178	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ARNTL—coronary artery disease	1.14e-05	0.000178	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—P4HB—coronary artery disease	1.13e-05	0.000177	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.12e-05	0.000175	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.12e-05	0.000175	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	1.11e-05	0.000173	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.1e-05	0.000171	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.1e-05	0.000171	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.09e-05	0.000171	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PLCB1—coronary artery disease	1.09e-05	0.00017	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.08e-05	0.00017	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GPX2—coronary artery disease	1.08e-05	0.000168	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOA2—coronary artery disease	1.08e-05	0.000168	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	1.08e-05	0.000168	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SULT1A1—coronary artery disease	1.06e-05	0.000166	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HK1—coronary artery disease	1.06e-05	0.000166	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCG5—coronary artery disease	1.06e-05	0.000166	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GPX4—coronary artery disease	1.06e-05	0.000166	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.06e-05	0.000166	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ABCA1—coronary artery disease	1.05e-05	0.000165	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HADHA—coronary artery disease	1.05e-05	0.000164	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HK2—coronary artery disease	1.05e-05	0.000164	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.05e-05	0.000164	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—VCAN—coronary artery disease	1.05e-05	0.000164	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA1—coronary artery disease	1.04e-05	0.000162	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALDOA—coronary artery disease	1.04e-05	0.000162	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—LPA—coronary artery disease	1.03e-05	0.000161	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GGT1—coronary artery disease	1.02e-05	0.00016	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GOT1—coronary artery disease	1.02e-05	0.00016	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—DCN—coronary artery disease	1.01e-05	0.000158	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1e-05	0.000157	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PLCB3—coronary artery disease	9.94e-06	0.000156	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOA5—coronary artery disease	9.84e-06	0.000154	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CPT1B—coronary artery disease	9.83e-06	0.000154	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—LCAT—coronary artery disease	9.83e-06	0.000154	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALDH2—coronary artery disease	9.79e-06	0.000153	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—P4HB—coronary artery disease	9.65e-06	0.000151	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOA4—coronary artery disease	9.65e-06	0.000151	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	9.56e-06	0.00015	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	9.55e-06	0.000149	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HBA1—coronary artery disease	9.54e-06	0.000149	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—LIPC—coronary artery disease	9.54e-06	0.000149	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2C19—coronary artery disease	9.54e-06	0.000149	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	9.54e-06	0.000149	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—APOC3—coronary artery disease	9.48e-06	0.000148	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	9.47e-06	0.000148	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—LDLR—coronary artery disease	9.43e-06	0.000147	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	9.42e-06	0.000147	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	9.37e-06	0.000147	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GCLM—coronary artery disease	9.32e-06	0.000146	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PDHA1—coronary artery disease	9.32e-06	0.000146	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTT1—coronary artery disease	9.31e-06	0.000146	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SLC9A1—coronary artery disease	9.31e-06	0.000146	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	9.26e-06	0.000145	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CETP—coronary artery disease	9.21e-06	0.000144	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GCLC—coronary artery disease	9.21e-06	0.000144	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTP1—coronary artery disease	9.18e-06	0.000144	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SDC1—coronary artery disease	9.1e-06	0.000142	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPARGC1A—coronary artery disease	9.09e-06	0.000142	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HMOX1—coronary artery disease	9.05e-06	0.000142	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—TXNRD1—coronary artery disease	9.02e-06	0.000141	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP11B2—coronary artery disease	9.02e-06	0.000141	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CAT—coronary artery disease	8.93e-06	0.00014	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—VCAN—coronary artery disease	8.93e-06	0.00014	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC22A3—coronary artery disease	8.89e-06	0.000139	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALDOA—coronary artery disease	8.86e-06	0.000139	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ARNTL—coronary artery disease	8.76e-06	0.000137	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HADH—coronary artery disease	8.76e-06	0.000137	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—APOB—coronary artery disease	8.67e-06	0.000136	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—DCN—coronary artery disease	8.6e-06	0.000135	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PSMB5—coronary artery disease	8.6e-06	0.000135	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PSMA6—coronary artery disease	8.6e-06	0.000135	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	8.58e-06	0.000134	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTM1—coronary artery disease	8.43e-06	0.000132	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CTGF—coronary artery disease	8.4e-06	0.000131	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALDH2—coronary artery disease	8.37e-06	0.000131	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GOT2—coronary artery disease	8.33e-06	0.00013	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HMGCR—coronary artery disease	8.33e-06	0.00013	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOA2—coronary artery disease	8.3e-06	0.00013	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GPX2—coronary artery disease	8.3e-06	0.00013	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	8.3e-06	0.00013	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—LPL—coronary artery disease	8.28e-06	0.00013	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCG5—coronary artery disease	8.2e-06	0.000128	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HK1—coronary artery disease	8.2e-06	0.000128	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SULT1A1—coronary artery disease	8.2e-06	0.000128	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GPX4—coronary artery disease	8.2e-06	0.000128	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	8.16e-06	0.000128	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	8.15e-06	0.000128	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2C19—coronary artery disease	8.15e-06	0.000128	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—LIPC—coronary artery disease	8.15e-06	0.000128	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HBA1—coronary artery disease	8.15e-06	0.000128	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HADHA—coronary artery disease	8.11e-06	0.000127	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOC3—coronary artery disease	8.1e-06	0.000127	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GPX1—coronary artery disease	8.08e-06	0.000126	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—LDLR—coronary artery disease	8.06e-06	0.000126	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	8.05e-06	0.000126	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA1—coronary artery disease	8.01e-06	0.000125	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC9A1—coronary artery disease	7.96e-06	0.000125	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTT1—coronary artery disease	7.96e-06	0.000125	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—LPA—coronary artery disease	7.92e-06	0.000124	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CETP—coronary artery disease	7.87e-06	0.000123	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GCLC—coronary artery disease	7.87e-06	0.000123	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CD36—coronary artery disease	7.87e-06	0.000123	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SDC1—coronary artery disease	7.78e-06	0.000122	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPP2CA—coronary artery disease	7.77e-06	0.000122	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PLCB3—coronary artery disease	7.67e-06	0.00012	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PLCB1—coronary artery disease	7.66e-06	0.00012	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOA5—coronary artery disease	7.6e-06	0.000119	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	7.51e-06	0.000118	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MTHFR—coronary artery disease	7.45e-06	0.000117	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—P4HB—coronary artery disease	7.45e-06	0.000117	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ABCA1—coronary artery disease	7.42e-06	0.000116	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PSMA6—coronary artery disease	7.35e-06	0.000115	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PSMB5—coronary artery disease	7.35e-06	0.000115	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	7.34e-06	0.000115	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	7.31e-06	0.000114	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GGT1—coronary artery disease	7.19e-06	0.000112	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GOT1—coronary artery disease	7.19e-06	0.000112	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CTGF—coronary artery disease	7.18e-06	0.000112	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HMGCR—coronary artery disease	7.12e-06	0.000111	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GOT2—coronary artery disease	7.12e-06	0.000111	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AGT—coronary artery disease	7.08e-06	0.000111	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—APOE—coronary artery disease	6.94e-06	0.000109	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—VCAN—coronary artery disease	6.89e-06	0.000108	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—APOA1—coronary artery disease	6.86e-06	0.000107	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALDOA—coronary artery disease	6.84e-06	0.000107	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—DCN—coronary artery disease	6.64e-06	0.000104	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PLCB1—coronary artery disease	6.54e-06	0.000102	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALDH2—coronary artery disease	6.46e-06	0.000101	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTP1—coronary artery disease	6.46e-06	0.000101	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	6.42e-06	0.0001	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	6.4e-06	0.0001	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HMOX1—coronary artery disease	6.37e-06	9.96e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCA1—coronary artery disease	6.34e-06	9.92e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—LIPC—coronary artery disease	6.29e-06	9.85e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HBA1—coronary artery disease	6.29e-06	9.85e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	6.29e-06	9.85e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2C19—coronary artery disease	6.29e-06	9.85e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CAT—coronary artery disease	6.28e-06	9.83e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOC3—coronary artery disease	6.25e-06	9.79e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—LDLR—coronary artery disease	6.22e-06	9.73e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC9A1—coronary artery disease	6.14e-06	9.61e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTT1—coronary artery disease	6.14e-06	9.61e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GOT1—coronary artery disease	6.14e-06	9.61e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GGT1—coronary artery disease	6.14e-06	9.61e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—APOB—coronary artery disease	6.1e-06	9.54e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GCLC—coronary artery disease	6.07e-06	9.5e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CETP—coronary artery disease	6.07e-06	9.5e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPARG—coronary artery disease	6.04e-06	9.46e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SDC1—coronary artery disease	6e-06	9.39e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—POMC—coronary artery disease	5.96e-06	9.33e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTM1—coronary artery disease	5.93e-06	9.28e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—LPL—coronary artery disease	5.82e-06	9.11e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GPX1—coronary artery disease	5.68e-06	8.89e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PSMB5—coronary artery disease	5.67e-06	8.87e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PSMA6—coronary artery disease	5.67e-06	8.87e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CTGF—coronary artery disease	5.54e-06	8.67e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CD36—coronary artery disease	5.53e-06	8.66e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTP1—coronary artery disease	5.52e-06	8.63e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HMGCR—coronary artery disease	5.49e-06	8.59e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GOT2—coronary artery disease	5.49e-06	8.59e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	5.47e-06	8.55e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPP2CA—coronary artery disease	5.46e-06	8.55e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HMOX1—coronary artery disease	5.44e-06	8.51e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALB—coronary artery disease	5.43e-06	8.5e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CAT—coronary artery disease	5.37e-06	8.4e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTHFR—coronary artery disease	5.24e-06	8.2e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOB—coronary artery disease	5.21e-06	8.15e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NOS3—coronary artery disease	5.2e-06	8.13e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTM1—coronary artery disease	5.07e-06	7.93e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PLCB1—coronary artery disease	5.05e-06	7.9e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AGT—coronary artery disease	4.98e-06	7.79e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—LPL—coronary artery disease	4.98e-06	7.79e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCA1—coronary artery disease	4.89e-06	7.66e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—APOE—coronary artery disease	4.88e-06	7.64e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GPX1—coronary artery disease	4.86e-06	7.6e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—APOA1—coronary artery disease	4.83e-06	7.55e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTGS2—coronary artery disease	4.75e-06	7.44e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GOT1—coronary artery disease	4.74e-06	7.42e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GGT1—coronary artery disease	4.74e-06	7.42e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CD36—coronary artery disease	4.73e-06	7.4e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPP2CA—coronary artery disease	4.67e-06	7.31e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.62e-06	7.23e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTHFR—coronary artery disease	4.48e-06	7.01e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTP1—coronary artery disease	4.26e-06	6.66e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AGT—coronary artery disease	4.26e-06	6.66e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPARG—coronary artery disease	4.25e-06	6.65e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	4.22e-06	6.6e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HMOX1—coronary artery disease	4.2e-06	6.57e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—POMC—coronary artery disease	4.19e-06	6.56e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOE—coronary artery disease	4.17e-06	6.53e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CAT—coronary artery disease	4.14e-06	6.48e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOA1—coronary artery disease	4.12e-06	6.45e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOB—coronary artery disease	4.02e-06	6.29e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.95e-06	6.18e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTM1—coronary artery disease	3.91e-06	6.12e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—LPL—coronary artery disease	3.84e-06	6.01e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALB—coronary artery disease	3.82e-06	5.98e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GPX1—coronary artery disease	3.75e-06	5.86e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NOS3—coronary artery disease	3.66e-06	5.72e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CD36—coronary artery disease	3.65e-06	5.71e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPARG—coronary artery disease	3.63e-06	5.68e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPP2CA—coronary artery disease	3.6e-06	5.64e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—POMC—coronary artery disease	3.58e-06	5.61e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTHFR—coronary artery disease	3.46e-06	5.41e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTGS2—coronary artery disease	3.34e-06	5.23e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AGT—coronary artery disease	3.29e-06	5.14e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALB—coronary artery disease	3.27e-06	5.11e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOE—coronary artery disease	3.22e-06	5.04e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOA1—coronary artery disease	3.18e-06	4.98e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NOS3—coronary artery disease	3.13e-06	4.89e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CA—coronary artery disease	2.93e-06	4.58e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTGS2—coronary artery disease	2.86e-06	4.47e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPARG—coronary artery disease	2.8e-06	4.39e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—POMC—coronary artery disease	2.77e-06	4.33e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALB—coronary artery disease	2.52e-06	3.94e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NOS3—coronary artery disease	2.41e-06	3.77e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AKT1—coronary artery disease	2.39e-06	3.74e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.21e-06	3.45e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CA—coronary artery disease	2.06e-06	3.22e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.76e-06	2.75e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AKT1—coronary artery disease	1.68e-06	2.63e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AKT1—coronary artery disease	1.44e-06	2.25e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.36e-06	2.12e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AKT1—coronary artery disease	1.11e-06	1.73e-05	CbGpPWpGaD
